Importer of Controlled Substances Registration, 45518-45519 [2019-18686]
Download as PDF
<![CDATA[
45518
Federal Register / Vol. 84, No. 168 / Thursday, August 29, 2019 / Notices
Comments should address whether
issuance of the relief specifically
requested by the complainant in this
investigation would affect the public
health and welfare in the United States,
competitive conditions in the United
States economy, the production of like
or directly competitive articles in the
United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) Explain how the articles
potentially subject to the requested
remedial orders are used in the United
States;
(ii) identify any public health, safety,
or welfare concerns in the United States
relating to the requested remedial
orders;
(iii) identify like or directly
competitive articles that complainant,
its licensees, or third parties make in the
United States which could replace the
subject articles if they were to be
excluded;
(iv) indicate whether complainant,
complainant’s licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the requested
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the requested
remedial orders would impact United
States consumers.
Written submissions on the public
interest must be filed no later than by
close of business, eight calendar days
after the date of publication of this
notice in the Federal Register. There
will be further opportunities for
comment on the public interest after the
issuance of any final initial
determination in this investigation. Any
written submissions on other issues
must also be filed by no later than the
close of business, eight calendar days
after publication of this notice in the
Federal Register. Complainant may file
replies to any written submissions no
later than three calendar days after the
date on which any initial submissions
were due. Any submissions and replies
filed in response to this Notice are
limited to five (5) pages in length,
inclusive of attachments.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to § 210.4(f)
of the Commission’s Rules of Practice
and Procedure (19 CFR 210.4(f)).
Submissions should refer to the docket
number (‘‘Docket No. 3407’’) in a
prominent place on the cover page and/
or the first page. (See Handbook for
Electronic Filing Procedures, Electronic
Filing Procedures 1). Persons with
questions regarding filing should
contact the Secretary (202–205–2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: August 26, 2019.
William Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2019–18663 Filed 8–28–19; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
The registrants listed below
have applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION:
The companies listed below applied
to be registered as an importers of
various basic classes of schedule I and
II controlled substances. Information on
previously published notices is listed in
the table below. No comments or
objections were submitted and no
requests for a hearing were submitted
for these notices.
SUMMARY:
Companies
FR docket
Mylan Pharmaceuticals Inc ..............................................................................................................
Rhodes Technologies ......................................................................................................................
S & B Pharma, Inc ...........................................................................................................................
Wildlife Laboratories, Inc .................................................................................................................
khammond on DSKBBV9HB2PROD with NOTICES
Notice of registration.
84
84
84
84
FR
FR
FR
FR
18321
21807
21813
21809
.............
.............
.............
.............
Published
April 30, 2019.
May 15, 2019.
May 15, 2019.
May 15, 2019.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable various basic classes of
schedule I and II controlled substances
is consistent with the public interest
and with United States obligations
under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated each
of the company’s maintenance of
effective controls against diversion by
inspecting and testing each company’s
physical security systems, verifying
each company’s compliance with state
and local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
1 Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
2 All contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
VerDate Sep<11>2014
17:00 Aug 28, 2019
Jkt 247001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
E:\FR\FM\29AUN1.SGM
29AUN1
45519
Federal Register / Vol. 84, No. 168 / Thursday, August 29, 2019 / Notices
granted a registration as an importer for
schedule II controlled substances to the
above listed companies.
DEPARTMENT OF JUSTICE
Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[Docket No. DEA–392]
Administration (DEA) as importers of
schedule I and II controlled substances.
Drug Enforcement Administration
Importer of Controlled Substances
Registration
[FR Doc. 2019–18686 Filed 8–28–19; 8:45 am]
ACTION:
BILLING CODE 4410–09–P
Notice of registration.
The registrants listed below
have applied for and been granted
registration by the Drug Enforcement
SUMMARY:
The
companies listed below applied to be
registered as an importers of various
basic classes of schedule I and II
controlled substances. Information on
previously published notices is listed in
the table below. No comments or
objections were submitted and no
requests for a hearing were submitted
for these notices.
SUPPLEMENTARY INFORMATION:
Companies
Unither Manufacturing, LLC .................................................................................................................................
Shertech Laboratories, LLC .................................................................................................................................
khammond on DSKBBV9HB2PROD with NOTICES
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable various basic classes of
schedule I and II controlled substances
is consistent with the public interest
and with United States obligations
under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated each
of the company’s maintenance of
effective controls against diversion by
inspecting and testing each company’s
physical security systems, verifying
each company’s compliance with state
and local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule II controlled substances to the
above listed companies.
Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
FR docket
Published
84 FR 13961
84 FR 26446
April 8, 2019.
June 6, 2019.
The registrants listed below
have applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
schedule I and II controlled substances.
SUMMARY:
The
companies listed below applied to be
registered as an importers of various
basic classes of schedule I and II
controlled substances. Information on
previously published notices is listed in
the table below. No comments or
objections were submitted and no
requests for a hearing were submitted
for these notices.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–18688 Filed 8–28–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
Companies
FR docket
United States Pharmacopeial Convention .......................................................................................
Bellwyck Clinical Services ...............................................................................................................
84 FR 23582 .............
84 FR 31622 .............
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable various basic classes of
schedule I and II controlled substances
is consistent with the public interest
and with United States obligations
under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated each
of the company’s maintenance of
effective controls against diversion by
inspecting and testing each company’s
physical security systems, verifying
each company’s compliance with state
and local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
VerDate Sep<11>2014
17:00 Aug 28, 2019
Jkt 247001
granted a registration as an importer for
schedule I and II controlled substances
to the above listed companies.
Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019–18685 Filed 8–28–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Published
May 22, 2019.
July 2, 2019.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 28, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 15, 2019, Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402 applied
to be registered as a bulk manufacturer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cerilliant
Corporation
ACTION:
PO 00000
Notice of application.
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\29AUN1.SGM
29AUN1
]]>Agencies
[Federal Register Volume 84, Number 168 (Thursday, August 29, 2019)]
[Notices]
[Pages 45518-45519]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18686]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as importers
of schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as an importers
of various basic classes of schedule I and II controlled substances.
Information on previously published notices is listed in the table
below. No comments or objections were submitted and no requests for a
hearing were submitted for these notices.
----------------------------------------------------------------------------------------------------------------
Companies FR docket Published
----------------------------------------------------------------------------------------------------------------
Mylan Pharmaceuticals Inc..................... 84 FR 18321.................... April 30, 2019.
Rhodes Technologies........................... 84 FR 21807.................... May 15, 2019.
S & B Pharma, Inc............................. 84 FR 21813.................... May 15, 2019.
Wildlife Laboratories, Inc.................... 84 FR 21809.................... May 15, 2019.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable various basic classes of schedule I and II
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each of the
company's maintenance of effective controls against diversion by
inspecting and testing each company's physical security systems,
verifying each company's compliance with state and local laws, and
reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has
[[Page 45519]]
granted a registration as an importer for schedule II controlled
substances to the above listed companies.
Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-18686 Filed 8-28-19; 8:45 am]
BILLING CODE 4410-09-P
